clopidogrel is given prophylactically in patients at risk of thrombo-embolic disorders such as myocardial infarction, peripheral arterial disease and stroke .
Patients with a known hypersensitivity to clopidogrel or to any of the excipients
Patients with haematopoietic disorders such as neutropenia or thrombocytopenia or other haemorrhagic disorders or conditions with an increased risk of bleeding such as gastro-intestinal ulcers or severe liver dysfunction.
Gastrointestinal hemorrhage occurred at rate of 2.0 %. neutropenia, abdominal pain, dyspepsia, constipation, peptic or duodenal ulcers, headache, fatigue, dizziness, diarrhea, pruritis, upper respiratory tract, palpitation, bleeding and clotting disorders.
DOSAGE AND ADMINISTRATION:
The recommended dose of Clopidogrel is 75mg once daily wither without food no dosage adjustment is necessary for elderly patients or patients with renal disease.
Boxes of 10,20,30 tablets.